Topic Highlight
Copyright ©The Author(s) 2016.
World J Hepatol. Jun 18, 2016; 8(17): 703-715
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.703
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Common parameters between hepatocellular carcinoma classifications and scores. AFP: Alpha-fetoprotein; CLIP: Cancer of the Liver Italian Program; BCLC: Barcelona Clinic Liver Cancer; JIS: Japan Integrated Staging; HKLC: Hong Kong Liver Cancer; TIS: Taipei Integrated Scoring System; ECOG (PS): Eastern Cooperative Oncology Group (performance status).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Barcelona Clinic Liver Cancer system. HCC: Hepatocellular carcinoma; PS: Performance status; TACE: Transarterial chemoembolization.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Asian Pacific Association for the Study of the Liver guidelines on the treatment algorithm for hepatocellular carcinoma. HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Hong Kong Liver Cancer classification. EVM: Extrahepatic vascular invasion/metastasis; BSC: Best supportive care; TACE: Transarterial chemoembolization; ECOG: Eastern Cooperative Oncology Group.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Evolution of the median overall survival according to the NIACE score in Barcelona Clinic Liver Cancer stage C patients from a French multicenter study, treated by sorafenib (black bars center 2, grey bars center 3, white bars center 4)[38]. BCLC: Barcelona Clinic Liver Cancer.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Evolution of the median overall survival according to the NIACE score in hepatocellular carcinoma patients from a French multicenter study treated by transarterial chemoembolization (grey bars center 1, black bars center 2)[60]. TACE: Transarterial chemoembolization.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Prognostic scores designed to transarterial chemoembolization, an aid to the decision making process: In practice. BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization; CT: Computed tomography; ART: Assessment for Retreatment with TACE; ECOG (PS), Eastern Cooperative Oncology Group (Performance Status); RFA: Radiofrequency ablation; HAP: Hepatoma Arterial-embolisation Prognostic; MRI: Magnetic resonance imaging.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Nomogram for hepatocellular carcinoma recurrence after radiofrequency ablation[67].
Figure 9
Open in New Tab Full Size Figure Download Figure
Figure 9 Evolution of the median overall survival according to the NIACE score in hepatocellular carcinoma patients from a French multicenter study treated by surgery/radiofrequency ablation (grey bars center 5, black bars center 1)[68]. RFA: Radiofrequency ablation.